Orthofix Medical (OFIX) Capital Expenditures (2010 - 2026)

Orthofix Medical (OFIX) has 17 years of Capital Expenditures data on file, last reported at $10.7 million in Q1 2026.

• For the quarter ending Q1 2026, Capital Expenditures rose 58.27% year-over-year to $10.7 million; the trailing twelve-month figure through Mar 2026 stood at $38.6 million (up 25.19% YoY), and the FY2025 full-year result was $34.6 million, down 0.72% from the prior year.
• Capital Expenditures for Q1 2026 stood at $10.7 million, down from $10.9 million in the prior quarter.
• Across five years, Capital Expenditures topped out at $21.9 million in Q3 2023 and bottomed at $5.1 million in Q3 2022.
• A 5-year average of $9.7 million and a median of $9.7 million in 2024 frame the typical range for Capital Expenditures.
• Across the five-year window, Capital Expenditures surged 326.6% in 2023 and slumped 73.43% in 2024, its largest moves.
• Tracing OFIX's Capital Expenditures over 5 years: stood at $7.0 million in 2022, then jumped by 133.61% to $16.4 million in 2023, then tumbled by 47.84% to $8.5 million in 2024, then grew by 27.5% to $10.9 million in 2025, then decreased by 1.99% to $10.7 million in 2026.
• According to Business Quant data, Capital Expenditures over the past three periods registered $10.7 million, $10.9 million, and $9.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison